Hundreds of Texas convenience stores are selling untested, highly addictive and potentially deadly drugs as over-the-counter ...

For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration (FDA).

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

A groundbreaking study suggests that IBS might be more of a brain issue than a gut disorder. Researchers found that ...

Scientists reveal how CBD could help ease chronic pain, anxiety, and mood disorders. Researchers have uncovered a potential ...

Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

Researchers have identified how CBD interacts with cannabinoid receptors to mitigate the negative effects of THC, the psychoactive component of cannabis.

Cebranopadol reduced pain intensity in patients following abdominoplasty surgery in the ALLEVIATE-1 clinical trial.

Naloxone is a fantastic tool in reducing opioid deaths, but gentler versions would be helpful for fighting overdose ...

The USPTO has granted a patent to Vistagen’s non-opioid oral product candidate AV-101 for neuropathic pain treatment.

Irritable bowel syndrome (IBS) is a common digestive disorder with unclear causes, affecting about 10% of the global population. Researchers have now discovered that opioid delta-receptor agonists may ...